Haptoglobin Genotype Is Predictive of Major Adverse Cardiac Events in the 1-year Period after Percutaneous Transluminal Coronary Angioplasty in Individuals with Diabetes
暂无分享,去创建一个
A. Kastrati | A. Schomig | A. Roguin | A. Levy | D. Aronson | W. Koch | Ariel Roguin | Andrew P Levy
[1] A. Roguin,et al. Haptoglobin type and 30-day mortality in diabetic individuals presenting with acute myocardial infarction. , 2003, Diabetes care.
[2] A. Levy,et al. Genetically Determined Heterogeneity in Hemoglobin Scavenging and Susceptibility to Diabetic Cardiovascular Disease , 2003, Circulation research.
[3] K. Jablonski,et al. Haptoglobin phenotype is an independent risk factor for cardiovascular disease in individuals with diabetes: The Strong Heart Study. , 2002, Journal of the American College of Cardiology.
[4] A. Kastrati,et al. Genotyping of the common haptoglobin Hp 1/2 polymorphism based on PCR. , 2002, Clinical chemistry.
[5] I. Hochberg,et al. Haptoglobin phenotype and coronary artery collaterals in diabetic patients. , 2002, Atherosclerosis.
[6] G. Matullo,et al. Haptoglobin phenotype and the risk of restenosis after coronary artery stent implantation. , 2002, The American journal of cardiology.
[7] B V Howard,et al. Diabetes and cardiovascular disease. , 2002, Annual review of medicine.
[8] A. Levy,et al. Structure-function analysis of the antioxidant properties of haptoglobin. , 2001, Blood.
[9] I. Hochberg,et al. Haptoglobin phenotype and diabetic nephropathy , 2001, Diabetologia.
[10] I. Hochberg,et al. Haptoglobin phenotype as a predictor of restenosis after percutaneous transluminal coronary angioplasty. , 2001, The American journal of cardiology.
[11] I. Hochberg,et al. Haptoglobin phenotype and vascular complications in patients with diabetes. , 2000, The New England journal of medicine.
[12] I. Hochberg,et al. Haptoglobin genotype as a risk factor for diabetic retinopathy. , 2000, JAMA.
[13] P. Ruszniewski,et al. Ulcerative colitis in a sigmoid neovagina. , 2000, The New England journal of medicine.
[14] A. Kastrati,et al. Insertion/deletion polymorphism of the angiotensin I-converting enzyme gene is not associated with restenosis after coronary stent placement. , 2000, Circulation.
[15] A. Kastrati,et al. Polymorphism of platelet glycoprotein IIb and risk of thrombosis and restenosis after coronary stent placement. , 1999, The American journal of cardiology.
[16] B. Howard,et al. Rising tide of cardiovascular disease in American Indians. The Strong Heart Study. , 1999, Circulation.
[17] A. Kastrati,et al. PlA polymorphism of platelet glycoprotein IIIa and risk of restenosis after coronary stent placement. , 1999, Circulation.
[18] R. Kuntz. Importance of considering atherosclerosis progression when choosing a coronary revascularization strategy: the diabetes-percutaneous transluminal coronary angioplasty dilemma. , 1999, Circulation.
[19] R. Califf,et al. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Aypass Angioplasty Revascularization Investigation (BARI). , 1999, Circulation.
[20] Ethnicity and Cardiovascular Disease: The incidence of myocardial infarction in white, South Asian, and Afro-Caribbean patients with type 2 diabetes (U.K. Prospective Diabetes Study 32) , 1998, Diabetes Care.
[21] R. Califf,et al. Relationship between diabetes mellitus and long-term survival after coronary bypass and angioplasty. , 1997, Circulation.
[22] T. B. Investigators,et al. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease: the Bypass Angioplasty Revascularization Investigation (BARI) , 1997, Circulation.
[23] J. Herlitz,et al. Mortality and Morbidity in Diabetic and Nondiabetic Patients During a 2-Year Period After Coronary Artery Bypass Grafting , 1996, Diabetes Care.
[24] W. Weintraub,et al. Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty. , 1995, Circulation.
[25] G. Vetrovec,et al. Coronary collateral recruitment: functional significance and relation to rate of vessel closure. , 1991, American heart journal.
[26] E. Jones,et al. Outcome of coronary bypass surgery versus coronary angioplasty in diabetic patients with multivessel coronary artery disease. , 1998, Journal of the American College of Cardiology.
[27] J. Willerson. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. , 1996, Circulation.
[28] A. Kurosky,et al. Haptoglobin: the evolutionary product of duplication, unequal crossing over, and point mutation. , 1982, Advances in human genetics.